Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole for Prevention of OHSS in IVF
NCT02670304Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Jan 2012
- Primary completion
- Jul 2013
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of letrozole in ovarian hyperstimulation syndrome (OHSS), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Started Jan 2012; status: completed.
02
Drugs
letrozole
03
Conditions
ovarian hyperstimulation syndrome (OHSS)
Beyond the preview
Go deeper on NCT02670304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02670304.